Blood test may outsmart MRI in spotting silent MS Flare-Ups
NCT ID NCT07292480
First seen Jan 09, 2026 · Last updated May 23, 2026 · Updated 23 times
Summary
This study compares monthly blood tests for a nerve damage marker (NfL) against standard yearly MRI scans in people with relapsing-remitting MS. The goal is to see if the blood test can catch hidden disease activity sooner, allowing faster treatment changes. About 84 participants will be monitored for up to 24 months.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS (MS) - RELAPSING-REMITTING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Nice
RECRUITINGNice, France
Contact Email: •••••@•••••
-
CHU de Nîmes
RECRUITINGNîmes, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.